Morepen Labs board approves POC medical devices biz into wholly-owned subsidiary
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Shares of Morepen Labs settled 2.62 per cent higher at Rs 68.45 apiece on the BSE.
Morepen Laboratories reported a net profit of Rs 30.47 crore on a consolidated basis in the April-June of the financial year 2021-22, compared to Rs 19.37 crore in the corresponding quarter last year, marking a growth of 57 per cent year-on-year. The leading pharmaceutical company announced its first quarter results for the current fiscal year on Tuesday, July 27, after which its share price gained around three per cent during the trading session.
Morepen Laboratories opened on the BSE at Rs 67.85, swinging to an intra day high of Rs 71, and an intra day low of Rs 66.60, throughout the trading session today. Shares of Morepen Labs settled 2.62 per cent higher at Rs 68.45 apiece on the BSE.
Market ahead: Ahead of Market: 12 things that will decide stock action on Friday
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
RDIF says gap between two Sputnik V doses can be increased to 180 days: Report
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Sputnik V Vaccine: Morepen Labs commences producing test batch at Himachal facility
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.